Gene: DRAM2
Official Full Name: DNA damage regulated autophagy modulator 2provided by HGNC
Gene Summary: The protein encoded by this gene binds microtubule-associated protein 1 light chain 3 and is required for autophagy. Defects in this gene are a cause of retinal dystrophy. In addition, two microRNAs (microRNA 125b-1 and microRNA 144) can bind to the mRNA of this gene and produce the disease state. [provided by RefSeq, Mar 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26773 | DRAM2 Knockout cell line (HeLa) | Human | DRAM2 | 1:3~1:6 | Negative | Online Inquiry |
KO26774 | DRAM2 Knockout cell line (HCT 116) | Human | DRAM2 | 1:2~1:4 | Negative | Online Inquiry |
KO26775 | DRAM2 Knockout cell line (HEK293) | Human | DRAM2 | 1:3~1:6 | Negative | Online Inquiry |
KO26776 | DRAM2 Knockout cell line (A549) | Human | DRAM2 | 1:3~1:4 | Negative | Online Inquiry |
DRAM2 Gene Knockout Cell Lines are specialized cellular models engineered to lack the expression of the DNA damage-regulated autophagy modulator 2 (DRAM2) gene. This innovative product provides researchers with a unique tool to study the role of DRAM2 in various biological processes, such as cellular autophagy, stress responses, and cancer biology. By deleting this gene, scientists can investigate the cellular pathways that are altered in its absence, specifically looking at how DRAM2 influences apoptosis, DNA repair mechanisms, and autophagy-mediated cellular homeostasis.
The key function of DRAM2 involves its participation in the autophagy pathway, serving as a modulator that influences the process of cellular degradation and recycling of components. In the knockout cell lines, researchers can directly observe the impacts of DRAM2 deficiency on autophagic flux, mitochondrial function, and responses to oxidative stress, offering insights into how these pathways contribute to disease models. Such observations could lead to new therapeutic strategies, particularly in oncology, where autophagy plays a dual role in tumor progression and cell survival.
The scientific importance of these knockout cell lines extends to their applications in both fundamental research and clinical settings. For instance, they can be used to develop or test new drugs aimed at regulating autophagy, contributing to cancer therapies or neurodegenerative disease treatments. The model can also elucidate the mechanisms of action of various chemotherapeutic agents and their effectiveness against cancer cells with altered autophagic responses.
Compared to other cell line models, DRAM2 Gene Knockout Cell Lines stand out due to their specificity and targeted approach to studying autophagy modulation, enabling more precise experimentation. This specificity mitigates background noise typically associated with less-defined knockout models and allows for clearer interpretation of data.
For researchers and clinicians focused on autophagy or cell death pathways, these cell lines offer unparalleled value by facilitating detailed investigations into critical cellular functions and disease mechanisms.
With our extensive experience in producing high-quality biological products tailored to the needs of researchers and clinicians, our commitment to advancing scientific discovery is exemplified in the robustness and reliability of the DRAM2 Gene Knockout Cell Lines. We empower our users to unlock new insights and innovations in their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.